NEUROPACE, INC. Payments to Acquire Debt Securities, Available-for-sale
NEUROPACE, INC. (NPCE) reported Payments to Acquire Debt Securities, Available-for-sale of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2022-11-08
- NEUROPACE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2021-09-30 was $12.00K, a 95.20% decline year-over-year.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | ||
| 2021-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $80.01M derived: sum of 2 quarters · filed 2022-11-08 | $85.01M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $80.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $85.00M 10-Q · filed 2022-08-11 | |
| 2021-03-31 | $5.00M 10-Q · filed 2022-05-12 | ||
| 2020-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $250.00K derived: sum of 2 quarters · filed 2021-11-10 | $7.00M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.75M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $6.75M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |